$22.00
-0.62-2.74%
Pre-Market: Apr 4, 7:56 PM EDT
Comments
Loading...
Viking Therapeutics Insider Trading Activity | NASDAQ:VKTX | Benzinga
Track the latest Viking Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Viking Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Viking Therapeutics Inc Insiders Doing?
At Viking Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 1.24K shares for a total value of $29.94K.
Notable Recent Insider Buys and Sales
- On April 2, 2025, Kathryn Sarah Rouan, the company's - purchased 1.24K shares for $24.15 each.
Ownership Statistics for Viking Therapeutics Inc
Shares Outstanding
112.248M
Insider Shares Owned
4.396M
Insider Percentage Owned
3.92%
Institutional Shares Held
56.499M
Institutional Percentage Held
50.3%
| Apr 02, 2025 | Kathryn Sarah Rouan | — | 1.24K | $24.15 | $29.94K | BUY | ∞ | 1.24K | Mar 31 | View |
| Jan 06, 2025 | Brian Lian | PRESIDENT & CEO | 61.64K | $42.75 | -$8.31M | GRANT | 2.67% | 2.37M | Jan 03 - Jan 06 | View |
| Jan 06, 2025 | Marianna Mancini | CHIEF OPERATING OFFICER | 11.98K | $42.75 | -$2.32M | GRANT | 3.31% | 374.13K | Jan 03 - Jan 06 | View |
| Jan 06, 2025 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 15.89K | $42.75 | -$2.15M | GRANT | 10.64% | 165.26K | Jan 03 - Jan 06 | View |
| Nov 08, 2024 | LAWSON MACARTNEY | — | 0.00 | $37.23 | -$125.73K | SELL-OPTIONS | 0.00% | 47.97K | Nov 08 | View |
| Oct 28, 2024 | GREG ZANTE | CHIEF FINANCIAL OFFICER | -37.69K | $42.05 | -$9.38M | SELL | -20.15% | 149.37K | Oct 28 | View |
| Oct 25, 2024 | Kathryn Sarah Rouan | — | 0.00 | $42.88 | -$836.11K | SELL-OPTIONS | 0.00% | 0.00 | Oct 25 | View |
| Oct 25, 2024 | MATTHEW SINGLETON | — | 0.00 | $41.99 | -$1.20M | SELL-OPTIONS | 0.00% | 9.50K | Oct 25 | View |
| Sep 20, 2024 | MATTHEW SINGLETON | — | 0.00 | $35.34 | -$703.59K | SELL-OPTIONS | 0.00% | 9.50K | Sep 20 | View |
| Sep 20, 2024 | Brian Lian | PRESIDENT & CEO | -50.00K | $39.30 | -$14.02M | SELL | -2.12% | 2.30M | Sep 20 | View |
| Aug 22, 2024 | Brian Lian | PRESIDENT & CEO | 0.00 | $38.84 | -$62.13K | SELL-OPTIONS | 0.00% | 2.35M | Aug 21 | View |
| Aug 22, 2024 | MATTHEW SINGLETON | — | 0.00 | $35.46 | -$390.65K | SELL-OPTIONS | 0.00% | 9.50K | Aug 21 | View |
| Aug 19, 2024 | Brian Lian | PRESIDENT & CEO | 0.00 | $36.78 | -$6.55M | SELL-OPTIONS | 0.00% | 2.35M | Aug 19 | View |
| Aug 19, 2024 | MATTHEW SINGLETON | — | 0.00 | $32.77 | -$942.17K | SELL-OPTIONS | 0.00% | 9.50K | Aug 19 | View |
| Aug 14, 2024 | MATTHEW SINGLETON | — | 0.00 | $32.76 | -$1.03M | SELL-OPTIONS | 0.00% | 9.50K | Aug 14 | View |
| Jul 31, 2024 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 12.20K | $57.15 | -$922.21K | GRANT | 6.98% | 187.05K | Jul 29 - Jul 30 | View |
| Jul 31, 2024 | Marianna Mancini | CHIEF OPERATING OFFICER | 13.64K | $57.13 | -$1.03M | GRANT | 3.91% | 362.15K | Jul 29 - Jul 30 | View |
| Jul 31, 2024 | Brian Lian | PRESIDENT & CEO | 88.47K | $57.58 | -$6.67M | GRANT | 3.90% | 2.35M | Jul 29 - Jul 30 | View |
| May 03, 2024 | GREG ZANTE | CHIEF FINANCIAL OFFICER | -32.51K | $39.77 | -$4.82M | SELL | -15.68% | 174.85K | May 03 | View |
| May 02, 2024 | Marianna Mancini | CHIEF OPERATING OFFICER | 0.00 | $42.42 | -$20.40M | SELL-OPTIONS | 0.00% | 348.51K | May 01 | View |
| Feb 09, 2024 | Brian Lian | PRESIDENT & CEO | -45.00K | $29.90 | -$1.35M | SELL | -2.06% | 2.14M | Feb 09 | View |
| Feb 08, 2024 | Brian Lian | PRESIDENT & CEO | -80.00K | $15.32 | -$6.52M | SELL | -3.53% | 2.18M | Feb 08 | View |
| Feb 08, 2024 | Kathryn Sarah Rouan | DIRECTOR | 0.00 | $18.19 | -$493.25K | SELL-OPTIONS | 0.00% | 0.00 | Feb 08 | View |
| Jan 31, 2024 | Brian Lian | PRESIDENT & CEO | 0.00 | $12.97 | -$2.00M | SELL-OPTIONS | 0.00% | 2.26M | Jan 31 | View |
| Jan 30, 2024 | Brian Lian | PRESIDENT & CEO | 0.00 | $12.59 | -$795.20K | SELL-OPTIONS | 0.00% | 2.26M | Jan 30 | View |
| Jan 19, 2024 | Kathryn Sarah Rouan | DIRECTOR | 0.00 | $15.69 | -$441.90K | SELL-OPTIONS | 0.00% | 0.00 | Jan 19 | View |
| Jan 04, 2024 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 20.34K | $17.71 | -$1.38M | GRANT | 12.68% | 180.73K | Jan 03 - Jan 04 | View |
| May 18, 2023 | Charles Rowland Jr | DIRECTOR | 0.00 | $13.04 | -$956.80K | SELL-OPTIONS | 0.00% | 30.00K | May 16 | View |
| May 18, 2023 | LAWSON MACARTNEY | DIRECTOR | 0.00 | $12.60 | -$364.96K | SELL-OPTIONS | 0.00% | 47.97K | May 16 | View |
| May 01, 2023 | Brian Lian | PRESIDENT & CEO | -45.00K | $22.45 | -$1.01M | SELL | -2.01% | 2.20M | May 01 | View |
| Apr 24, 2023 | LAWSON MACARTNEY | DIRECTOR | 0.00 | $12.67 | -$298.78K | SELL-OPTIONS | 0.00% | 47.97K | Apr 24 | View |
| Apr 21, 2023 | Brian Lian | PRESIDENT & CEO | -35.00K | $21.45 | -$750.75K | SELL | -1.54% | 2.24M | Apr 19 | View |
| Apr 18, 2023 | LAWSON MACARTNEY | DIRECTOR | 0.00 | $14.00 | -$249.43K | SELL-OPTIONS | 0.00% | 47.97K | Apr 17 | View |
| Apr 18, 2023 | Brian Lian | PRESIDENT & CEO | -30.00K | $11.30 | -$2.90M | SELL | -1.30% | 2.28M | Apr 17 | View |
| Apr 18, 2023 | Marianna Mancini | CHIEF OPERATING OFFICER | 0.00 | $16.54 | -$86.63K | SELL-OPTIONS | 0.00% | 287.76K | Apr 17 | View |
| Apr 18, 2023 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 0.00 | $16.54 | -$51.98K | SELL-OPTIONS | 0.00% | 149.28K | Apr 17 | View |
| Apr 13, 2023 | Brian Lian | PRESIDENT & CEO | -25.00K | $10.16 | -$1.36M | SELL | -1.07% | 2.31M | Apr 13 | View |
| Apr 13, 2023 | GREG ZANTE | CHIEF FINANCIAL OFFICER | 0.00 | $11.79 | -$1.22M | SELL-OPTIONS | 0.00% | 149.28K | Apr 11 - Apr 12 | View |
| Apr 03, 2023 | Brian Lian | PRESIDENT & CEO | 60.00K | $11.10 | -$6.75M | SELL-OPTIONS | 2.64% | 2.33M | Mar 30 - Apr 03 | View |
| Apr 03, 2023 | GREG ZANTE | CHIEF FINANCIAL OFFICER | -35.78K | $12.35 | -$2.83M | SELL | -19.33% | 149.28K | Mar 30 - Apr 03 | View |
| Mar 30, 2023 | Marianna Mancini | CHIEF OPERATING OFFICER | -55.38K | $9.05 | -$3.07M | SELL | -17.45% | 261.89K | Mar 28 - Mar 29 | View |
| May 03, 2022 | MATTHEW FOEHR | DIRECTOR | 45.00K | $2.47 | $111.19K | BUY | 67.92% | 111.25K | May 02 | View |
| Jun 10, 2021 | MATTHEW FOEHR | DIRECTOR | 20.00K | $5.69 | $113.80K | BUY | 43.24% | 66.25K | Jun 10 | View |
| Aug 27, 2020 | LIGAND PHARMACEUTICALS INC | — | -164.49K | $8.07 | -$1.33M | SELL | -2.75% | 5.82M | Aug 25 - Aug 26 | View |
| Jun 30, 2020 | MATTHEW FOEHR | — | -13.00K | $7.35 | -$95.55K | SELL | -33.12% | 26.25K | Jun 30 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.